JOSEPH PAPOTTO: Open Payments
NPI 1114970431 · MURRELLS INLET, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 10 payments from 7 companies in 2025. Trend: 2023 $143 · 2024 $122 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 2 | $132 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Novo Nordisk Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VOQUEZNA, GVOKE HYPOPEN, Yorvipath, Ozempic, Dexcom G6 Transmitter, QULIPTA, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
